| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium, Vascular | 9 | 2011 | 514 | 1.180 |
Why?
|
| Thioredoxins | 3 | 2010 | 23 | 1.010 |
Why?
|
| Nitric Oxide Synthase Type III | 8 | 2008 | 221 | 0.870 |
Why?
|
| Reactive Oxygen Species | 3 | 2010 | 479 | 0.810 |
Why?
|
| Aortic Aneurysm, Thoracic | 8 | 2013 | 648 | 0.760 |
Why?
|
| Up-Regulation | 9 | 2011 | 873 | 0.730 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2010 | 132 | 0.710 |
Why?
|
| Forkhead Transcription Factors | 4 | 2012 | 369 | 0.710 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2006 | 262 | 0.690 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2012 | 493 | 0.620 |
Why?
|
| Aorta | 7 | 2017 | 533 | 0.610 |
Why?
|
| Palmitic Acid | 4 | 2010 | 35 | 0.580 |
Why?
|
| RNA, Small Interfering | 7 | 2010 | 663 | 0.550 |
Why?
|
| Aortic Aneurysm | 2 | 2017 | 224 | 0.550 |
Why?
|
| Cells, Cultured | 15 | 2012 | 3074 | 0.510 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 2013 | 239 | 0.500 |
Why?
|
| Activating Transcription Factor 2 | 3 | 2010 | 15 | 0.480 |
Why?
|
| Endothelial Cells | 6 | 2010 | 527 | 0.470 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2013 | 93 | 0.430 |
Why?
|
| Pulmonary Medicine | 1 | 2013 | 26 | 0.430 |
Why?
|
| Histone Deacetylases | 2 | 2010 | 114 | 0.390 |
Why?
|
| Insulin | 2 | 2006 | 1191 | 0.370 |
Why?
|
| Gene Expression Regulation | 4 | 2010 | 2534 | 0.370 |
Why?
|
| Thrombomodulin | 1 | 2010 | 24 | 0.350 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 239 | 0.350 |
Why?
|
| MAP Kinase Signaling System | 3 | 2006 | 320 | 0.340 |
Why?
|
| Lung Diseases | 1 | 2013 | 384 | 0.330 |
Why?
|
| Metformin | 1 | 2010 | 137 | 0.310 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 165 | 0.300 |
Why?
|
| Cytomegalovirus | 2 | 2006 | 269 | 0.290 |
Why?
|
| Venous Thromboembolism | 1 | 2010 | 161 | 0.280 |
Why?
|
| Fatty Acids | 1 | 2009 | 337 | 0.280 |
Why?
|
| Gene Expression Regulation, Enzymologic | 5 | 2008 | 261 | 0.280 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 412 | 0.270 |
Why?
|
| Forkhead Box Protein O1 | 3 | 2012 | 95 | 0.270 |
Why?
|
| Aorta, Thoracic | 6 | 2013 | 517 | 0.270 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2006 | 136 | 0.260 |
Why?
|
| Resistin | 1 | 2006 | 36 | 0.260 |
Why?
|
| Cell Differentiation | 2 | 2013 | 1935 | 0.250 |
Why?
|
| Repressor Proteins | 1 | 2010 | 808 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 6 | 2012 | 1354 | 0.240 |
Why?
|
| Glucose | 1 | 2009 | 875 | 0.230 |
Why?
|
| Carrier Proteins | 1 | 2009 | 1015 | 0.220 |
Why?
|
| Cytomegalovirus Infections | 1 | 2005 | 218 | 0.220 |
Why?
|
| Procollagen-Proline Dioxygenase | 3 | 2008 | 35 | 0.210 |
Why?
|
| Angiotensin II | 2 | 2013 | 161 | 0.200 |
Why?
|
| Blotting, Western | 4 | 2010 | 1104 | 0.200 |
Why?
|
| China | 2 | 2013 | 224 | 0.190 |
Why?
|
| Signal Transduction | 5 | 2013 | 4511 | 0.180 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2010 | 239 | 0.180 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2012 | 138 | 0.160 |
Why?
|
| RNA, Messenger | 8 | 2013 | 2826 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 461 | 0.160 |
Why?
|
| Humans | 28 | 2017 | 122293 | 0.150 |
Why?
|
| Case-Control Studies | 4 | 2012 | 3229 | 0.150 |
Why?
|
| Phosphorylation | 3 | 2012 | 1613 | 0.140 |
Why?
|
| Protein Binding | 2 | 2012 | 1732 | 0.140 |
Why?
|
| Enzyme Activation | 3 | 2006 | 621 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 1296 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2012 | 160 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2012 | 3770 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2008 | 671 | 0.120 |
Why?
|
| Introns | 4 | 2008 | 303 | 0.120 |
Why?
|
| RNA | 2 | 2008 | 578 | 0.120 |
Why?
|
| Apoptosis | 3 | 2012 | 1790 | 0.120 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2014 | 34 | 0.120 |
Why?
|
| Chemistry, Clinical | 1 | 2014 | 13 | 0.110 |
Why?
|
| Aortitis | 1 | 2012 | 6 | 0.110 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2012 | 9 | 0.110 |
Why?
|
| Elastic Tissue | 1 | 2012 | 19 | 0.110 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 107 | 0.110 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2012 | 37 | 0.110 |
Why?
|
| PPAR gamma | 1 | 2013 | 92 | 0.110 |
Why?
|
| Enzyme Induction | 1 | 2012 | 105 | 0.110 |
Why?
|
| Thiazolidinediones | 1 | 2013 | 80 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 66 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 2010 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2012 | 79 | 0.100 |
Why?
|
| Apolipoproteins E | 2 | 2011 | 188 | 0.100 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 70 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2013 | 878 | 0.100 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2012 | 40 | 0.100 |
Why?
|
| Forecasting | 1 | 2013 | 355 | 0.100 |
Why?
|
| Cadmium | 1 | 2011 | 29 | 0.100 |
Why?
|
| Collagen Type III | 2 | 2013 | 21 | 0.100 |
Why?
|
| Atherosclerosis | 2 | 2011 | 828 | 0.090 |
Why?
|
| Vasculitis | 1 | 2011 | 49 | 0.090 |
Why?
|
| Public Health | 1 | 2013 | 252 | 0.090 |
Why?
|
| Collagen Type I | 2 | 2013 | 110 | 0.090 |
Why?
|
| DNA Primers | 2 | 2009 | 668 | 0.090 |
Why?
|
| Plasmids | 2 | 2009 | 516 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 356 | 0.090 |
Why?
|
| Reference Values | 1 | 2012 | 698 | 0.090 |
Why?
|
| Aged | 7 | 2014 | 18784 | 0.090 |
Why?
|
| Middle Aged | 8 | 2014 | 25639 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 83 | 0.090 |
Why?
|
| PPAR alpha | 1 | 2010 | 54 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1004 | 0.090 |
Why?
|
| Fenofibrate | 1 | 2010 | 57 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 282 | 0.080 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2009 | 25 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 197 | 0.080 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2009 | 24 | 0.080 |
Why?
|
| Transfection | 3 | 2006 | 1076 | 0.080 |
Why?
|
| Ribonucleotides | 1 | 2009 | 36 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2010 | 329 | 0.080 |
Why?
|
| Octamer Transcription Factors | 1 | 2008 | 8 | 0.080 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2008 | 24 | 0.080 |
Why?
|
| Gene Silencing | 2 | 2006 | 236 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1710 | 0.080 |
Why?
|
| Myocardium | 1 | 2013 | 980 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 3050 | 0.080 |
Why?
|
| Nucleotides | 1 | 2008 | 91 | 0.070 |
Why?
|
| Histones | 2 | 2008 | 530 | 0.070 |
Why?
|
| Antioxidants | 1 | 2010 | 337 | 0.070 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2007 | 7 | 0.070 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2007 | 11 | 0.070 |
Why?
|
| Disease Progression | 1 | 2013 | 1990 | 0.070 |
Why?
|
| Linoleic Acid | 1 | 2006 | 14 | 0.070 |
Why?
|
| Binding Sites | 2 | 2006 | 1292 | 0.070 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 58 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1592 | 0.070 |
Why?
|
| Oncogene Protein v-akt | 1 | 2005 | 30 | 0.070 |
Why?
|
| Mice | 3 | 2012 | 17546 | 0.060 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2005 | 18 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2005 | 56 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 113 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2010 | 477 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2005 | 75 | 0.060 |
Why?
|
| Hypertension | 2 | 2014 | 1274 | 0.060 |
Why?
|
| Elastin | 1 | 2005 | 31 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 1679 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 1370 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2005 | 148 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2010 | 798 | 0.060 |
Why?
|
| Animals | 5 | 2013 | 33721 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 565 | 0.060 |
Why?
|
| Male | 9 | 2014 | 59520 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 4366 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2006 | 1703 | 0.060 |
Why?
|
| Actins | 1 | 2005 | 339 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2006 | 447 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 9902 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 525 | 0.050 |
Why?
|
| Time Factors | 2 | 2014 | 6182 | 0.050 |
Why?
|
| Insulin Resistance | 1 | 2006 | 631 | 0.050 |
Why?
|
| Models, Biological | 1 | 2006 | 1438 | 0.050 |
Why?
|
| Cell Line | 1 | 2006 | 2782 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2013 | 126 | 0.040 |
Why?
|
| Gene Expression | 3 | 2012 | 1579 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2010 | 36 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2006 | 2578 | 0.040 |
Why?
|
| Inflammation | 1 | 2006 | 1392 | 0.040 |
Why?
|
| Female | 7 | 2014 | 64882 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2012 | 702 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 2573 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2012 | 12044 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2010 | 458 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2008 | 808 | 0.030 |
Why?
|
| Rats | 2 | 2013 | 3657 | 0.030 |
Why?
|
| DNA-Binding Proteins | 3 | 2008 | 2029 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2008 | 678 | 0.030 |
Why?
|
| Citric Acid | 1 | 2014 | 35 | 0.030 |
Why?
|
| Blood Specimen Collection | 1 | 2014 | 46 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 1822 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 98 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2013 | 63 | 0.030 |
Why?
|
| ADAMTS4 Protein | 1 | 2012 | 8 | 0.030 |
Why?
|
| ADAMTS1 Protein | 1 | 2012 | 16 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2013 | 116 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2013 | 75 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2013 | 121 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 107 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2012 | 122 | 0.030 |
Why?
|
| Base Sequence | 2 | 2008 | 3109 | 0.030 |
Why?
|
| Heparin | 1 | 2014 | 229 | 0.030 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 54 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2013 | 356 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 230 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 2013 | 118 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 3865 | 0.020 |
Why?
|
| Chaperonin 60 | 1 | 2011 | 32 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 326 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2011 | 63 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 816 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 1090 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2010 | 64 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2011 | 119 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 523 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 141 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2014 | 582 | 0.020 |
Why?
|
| Macrophages | 1 | 2012 | 611 | 0.020 |
Why?
|
| Collagen | 1 | 2010 | 311 | 0.020 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2008 | 12 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 17 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 168 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 140 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2796 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2008 | 459 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 427 | 0.020 |
Why?
|
| Compliance | 1 | 2006 | 17 | 0.020 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2006 | 19 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2006 | 64 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 94 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 130 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 2311 | 0.020 |
Why?
|
| Response Elements | 1 | 2006 | 99 | 0.020 |
Why?
|
| Luciferases | 1 | 2006 | 137 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 111 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2008 | 346 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 174 | 0.020 |
Why?
|
| Caspases | 1 | 2006 | 160 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 546 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2006 | 304 | 0.020 |
Why?
|
| Biomarkers | 1 | 2014 | 2933 | 0.020 |
Why?
|
| Adult | 3 | 2014 | 28732 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2005 | 384 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 4151 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 413 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 747 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 805 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2008 | 991 | 0.010 |
Why?
|
| DNA | 1 | 2006 | 1606 | 0.010 |
Why?
|
| Smoking | 1 | 2006 | 1028 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 2525 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1674 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 6290 | 0.010 |
Why?
|
| Adolescent | 1 | 2006 | 18940 | 0.000 |
Why?
|